Melinda Lantz, MD
Members of the American Association of Geriatric Psychiatry (AAGP) have elected Mount Sinai Beth Israel physician Melinda Lantz, MD, to become the organization’s President. Dr. Lantz, Vice Chair, Chief of Geriatric Psychiatry, and Associate Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, assumes her new role at a pivotal time.
Founded in 1978 to promote the well-being of older people through education, advocacy, and career development of psychiatrists, AAGP has embraced change. Its growing ranks now include nurses, physician assistants, and mental health professionals coping with a growing geriatric population.
Every day, an estimated 10,000 people reach age 65. Behavioral health problems affect 15 percent of older adults and up to 5 percent have serious mental illnesses, according to the federal Substance Abuse and Mental Health Services Administration. In 2013, more than 7,000 people age 65 or older died by suicide. Additionally, experts say direct health care costs associated with dementia in the elderly often equal or exceed the costs for heart disease and cancer.
In her role as President of AAGP, Dr. Lantz—a specialist in dementia care and geriatric mental illness—plans to address the need for additional recruitment and training by increasing interest in and availability of subspecialty fellowships in geriatric psychiatry. Boosting physician compensation for providing care to older adults with complex needs would also revitalize career opportunities.
Dr. Lantz would like to see an emphasis placed on empathy during training, a critical element for older patients who often cannot advocate for themselves. Elderly patients as a whole, she says, tend to like and respect doctors and welcome human contact.
Encouraging empathy in the treatment of patients “inspired me to be in the organization,” she says.
Too often, physicians lose empathy when they are stressed and have heavy workloads. “Everybody does better when they perceive empathy from physicians. One of the things that fellowships can do is help them get it back.”
After robust lobbying by the AAGP, the Centers for Medicare and Medicaid Services recently agreed to assign an insurance code to monitor the impact of geriatric psychiatry. “Getting that code suffix added was a major win,” says Dr. Lantz, who anticipates a favorable outcome once all of the factors are weighed. Tracking patients will show how geriatric psychiatry affects medical costs and resources.
Having spent billions of dollars researching dementia drugs with little success, many drugmakers have pulled back, according to Dr. Lantz. Today, she adds, “There are limited drug options for dementia in the pipeline. We need to focus on care and quality of life for those with dementia.”
An area that does show promise for helping in the treatment of geriatric psychiatry is technology. For elderly patients who are less mobile, telemedicine via videoconferencing can ease loneliness and increase access to care. Dr. Lantz says technology will also expand the scope of support to other health care providers who are located in communities where there are no specialists in geriatric psychiatry.
